Novo Nordisk gets FDA fast track status for ATTR heart disease drug

Go back to Novo Nordisk gets FDA fast track status for ATTR heart disease drug
NOVO-NORDISK A/S (NYSE: NVO) Delayed: 45.88 --0 (-0%)
Previous Close $45.88    52 Week High $59.00 
Open $45.88    52 Week Low $32.80 
Day High $45.88    P/E N/A 
Day Low $45.88    EPS $0.00 
Volume 214,558       

PROTHENA CORP (NASDAQ: PRTA) Delayed: 9.15 --0 (-0%)
Previous Close $9.15    52 Week High $76.42 
Open $9.15    52 Week Low $28.20 
Day High $9.15    P/E N/A 
Day Low $9.15    EPS $-2.84 
Volume